Regeneron Pharmaceuticals revenue was $7.86 b in FY, 2019 which is a 17.2% year over year increase from the previous period.
Regeneron Pharmaceuticals revenue breakdown by business segment: 28.9% from Sanofi and Bayer Collaboration, 68.7% from Product Sales and 2.5% from Other
|FY, 2019||FY, 2018||FY, 2017||FY, 2016|
|Sanofi and Bayer Collaboration||2.62 b||2.19 b||1.82 b||1.40 b|
|Product Sales||4.83 b||4.11 b||3.72 b||3.34 b|
|Other||413.40 m||416.80 m||338.52 m||119.10 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.